Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05369416 · ClinicalTrials.gov registry record · NA

Renal Metabolism in Salt-sensitive Human Blood Pressure

A NA study of Hypertension, sponsored by Medical College of Wisconsin.

Active
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05369416 is a NA study of Hypertension that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 70 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05369416, a NA study of Hypertension, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Salt sensitive hypertension is a significant health problem worldwide and a primary modifiable risk factor for renal, cardiovascular, and cerebrovascular diseases. Yet, the underlying mechanisms remain poorly understood. The proposed study determines how renal oxygenation and substrate metabolism differs between individuals with and without salt sensitivity, with the ultimate goal of identifying mechanisms, diagnostic criteria, and treatment strategies for salt sensitive hypertension.

Conditions Studied

Interventions

  • OTHER Low sodium diet
  • OTHER high sodium diet

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin /Froedtert Hospital - Milwaukee

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-11-01
Est. Completion 2030-01-30
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT05369416

The ClinicalTrials.gov registry entry for NCT05369416 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Low sodium diet is the first listed.

NCT05369416 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05369416 about?

NCT05369416 is a clinical study titled "Renal Metabolism in Salt-sensitive Human Blood Pressure". Salt sensitive hypertension is a significant health problem worldwide and a primary modifiable risk factor for renal, cardiovascular, and cerebrovascular diseases. Yet, the underlying mechanisms remain poorly understood. The proposed study determines how renal oxygenation and substrate metabolism d...

What is the current status of trial NCT05369416?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-11-01. Estimated completion is 2030-01-30.

What conditions does trial NCT05369416 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05369416?

The interventions under investigation include: Low sodium diet (OTHER), high sodium diet (OTHER).

Who is sponsoring clinical trial NCT05369416?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05369416 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.